ATE277035T1 - Substituierte oxime und hydrazone als neurokinin antagonisten - Google Patents
Substituierte oxime und hydrazone als neurokinin antagonistenInfo
- Publication number
- ATE277035T1 ATE277035T1 AT99968048T AT99968048T ATE277035T1 AT E277035 T1 ATE277035 T1 AT E277035T1 AT 99968048 T AT99968048 T AT 99968048T AT 99968048 T AT99968048 T AT 99968048T AT E277035 T1 ATE277035 T1 AT E277035T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrazones
- neurokinin antagonists
- substituted oximes
- oximes
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22031698A | 1998-12-23 | 1998-12-23 | |
| PCT/US1999/027953 WO2000039114A2 (en) | 1998-12-23 | 1999-12-21 | Substituted oximes and hydrazones as neurokinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277035T1 true ATE277035T1 (de) | 2004-10-15 |
Family
ID=22823070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99968048T ATE277035T1 (de) | 1998-12-23 | 1999-12-21 | Substituierte oxime und hydrazone als neurokinin antagonisten |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1144402B1 (de) |
| JP (2) | JP4370059B2 (de) |
| CN (1) | CN1414961A (de) |
| AR (1) | AR021968A1 (de) |
| AT (1) | ATE277035T1 (de) |
| AU (1) | AU2474200A (de) |
| CA (1) | CA2355886C (de) |
| CO (1) | CO5160341A1 (de) |
| DE (1) | DE69920516T2 (de) |
| ES (1) | ES2226493T3 (de) |
| HK (1) | HK1037182A1 (de) |
| PE (1) | PE20001353A1 (de) |
| TW (1) | TW533210B (de) |
| WO (1) | WO2000039114A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4370059B2 (ja) * | 1998-12-23 | 2009-11-25 | シェーリング コーポレイション | ニューロキニンアンタゴニストとしての置換オキシムおよびヒドラゾン |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| EP1918279A3 (de) | 2001-04-18 | 2008-07-16 | Euro-Celtique S.A. | 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazol-2-on derivate und verwandte verbindungen als nociceptin analoge und opioid rezeptor ähnlicher rezeptor (orl1) liganden zur behandlung von schmerz |
| UA75425C2 (en) * | 2001-07-09 | 2006-04-17 | Piperazine oxime derivatives with antagonistic activity to nk-1 receptor, use thereof, a pharmaceutical composition based thereon, a method for producing and a method for producing intermediary compounds | |
| EP1747221B1 (de) | 2004-04-07 | 2009-07-01 | Schering Corporation | Nk1-antagonisten mit kondensiertem ring |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| GB0506800D0 (en) * | 2005-04-04 | 2005-05-11 | Merck Sharp & Dohme | New uses |
| US8110681B2 (en) | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| EP2129381A1 (de) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Pharmazeutische zubereitungen enthaltend 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazin or r(-)-2,4-diamino-5-(2,3dichlorophenyl)-6-fluoromethyl pyrimidin und einen nk1- rezeptor-antagonisten |
| EP2387567B1 (de) | 2009-01-14 | 2014-06-11 | The Salk Institute for Biological Studies | Gegen amyloidkrankheiten schützende verbindungen |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321557D0 (en) * | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| US5688960A (en) * | 1995-05-02 | 1997-11-18 | Schering Corporation | Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
| US5696267A (en) * | 1995-05-02 | 1997-12-09 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| US5654316A (en) * | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
| TR200001437T2 (tr) * | 1997-11-21 | 2000-10-23 | Schering Corporation | Nörokinin muhasımlar olarak eşdeğer edilen oksimler. |
| JP4370059B2 (ja) * | 1998-12-23 | 2009-11-25 | シェーリング コーポレイション | ニューロキニンアンタゴニストとしての置換オキシムおよびヒドラゾン |
-
1999
- 1999-12-21 JP JP2000591025A patent/JP4370059B2/ja not_active Expired - Fee Related
- 1999-12-21 EP EP99968048A patent/EP1144402B1/de not_active Expired - Lifetime
- 1999-12-21 CA CA002355886A patent/CA2355886C/en not_active Expired - Fee Related
- 1999-12-21 CN CN99816349A patent/CN1414961A/zh active Pending
- 1999-12-21 AR ARP990106642A patent/AR021968A1/es unknown
- 1999-12-21 AU AU24742/00A patent/AU2474200A/en not_active Abandoned
- 1999-12-21 TW TW088122528A patent/TW533210B/zh active
- 1999-12-21 ES ES99968048T patent/ES2226493T3/es not_active Expired - Lifetime
- 1999-12-21 AT AT99968048T patent/ATE277035T1/de not_active IP Right Cessation
- 1999-12-21 PE PE1999001305A patent/PE20001353A1/es not_active Application Discontinuation
- 1999-12-21 DE DE69920516T patent/DE69920516T2/de not_active Expired - Lifetime
- 1999-12-21 WO PCT/US1999/027953 patent/WO2000039114A2/en active IP Right Grant
- 1999-12-21 CO CO99079878A patent/CO5160341A1/es unknown
-
2001
- 2001-10-30 HK HK01107545A patent/HK1037182A1/xx not_active IP Right Cessation
-
2006
- 2006-07-21 JP JP2006200127A patent/JP2006298939A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2355886C (en) | 2006-10-31 |
| EP1144402A3 (de) | 2002-09-11 |
| AR021968A1 (es) | 2002-09-04 |
| TW533210B (en) | 2003-05-21 |
| WO2000039114A2 (en) | 2000-07-06 |
| CA2355886A1 (en) | 2000-07-06 |
| EP1144402A2 (de) | 2001-10-17 |
| DE69920516T2 (de) | 2005-12-01 |
| DE69920516D1 (de) | 2004-10-28 |
| WO2000039114A3 (en) | 2001-11-29 |
| EP1144402B1 (de) | 2004-09-22 |
| CO5160341A1 (es) | 2002-05-30 |
| HK1037182A1 (en) | 2002-02-01 |
| JP2006298939A (ja) | 2006-11-02 |
| AU2474200A (en) | 2000-07-31 |
| ES2226493T3 (es) | 2005-03-16 |
| JP4370059B2 (ja) | 2009-11-25 |
| CN1414961A (zh) | 2003-04-30 |
| JP2002533451A (ja) | 2002-10-08 |
| PE20001353A1 (es) | 2000-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69904073T2 (de) | Oximderivate und ihre verwendung als latente saüre | |
| DE69908469T2 (de) | Mehrpegel-Phasentreiber und statische Stromwandler | |
| ATE297898T1 (de) | 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| ATE277906T1 (de) | 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| NO20006062D0 (no) | Innkapslede spaltningsstoffer, blandinger og fremgangsmåte for anvendelse derav | |
| DE69840474D1 (de) | Temperaturunempfindlicher siliziumoszillator und daraus erzeugte präzesionsspannungsreferenz | |
| ATE277035T1 (de) | Substituierte oxime und hydrazone als neurokinin antagonisten | |
| DE69935574D1 (de) | Antikörper gegen mensliches il-12 | |
| NO20010446D0 (no) | Substituert anilidforbindelser og metoder | |
| NO20010151D0 (no) | N-substituerte naftalenkarboksamider som neurokininreseptorantagonister | |
| NO20005266L (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
| DE69912533D1 (de) | Magnetische Befestigungsvorrichtung | |
| DE69201296T2 (de) | Verbesserungen und Änderungen für Weidezaunerreger. | |
| NO20024201D0 (no) | Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on og anvendelse derav for hemning av hormonsensitiv lipase | |
| NO20014131D0 (no) | Epitoper eller mimotoper avledet fra C-epsilon-3- eller C- epsilon-4-domener fra IgE, antagonister derav og deresterapeutiske anvendelser | |
| DE60031336D1 (de) | Schwingungsdämpfungseinrichtung und dazu passender, magnetischer Dämpfungsmechanismus | |
| NO20026168D0 (no) | 3-azabicyklo(3.1.0)heksan derivater med opioid reseptor affinitet | |
| DE60010346D1 (de) | Als überzüge verwendbare witterungsbeständige zusammensetzungen, verfahren, und damit überzogene artikel | |
| DE69917451D1 (de) | Sulfonylbenzolverbindungen als analgetische und entzündungshemmende mittel | |
| PT1044916E (pt) | Porta-bobinas | |
| DE19983695T1 (de) | Schaltkreissynthese und -verifizierung unter Berücksichtigung des relativen Zeitverhaltens | |
| DE60002569D1 (de) | Mischungen aus polyamiden und emulsionspolymeren | |
| ATE259355T1 (de) | Substituierte oxime als neurokinin antagonisten | |
| WO2002046156A3 (en) | 4,4-DISUBSTITUTED PIPERIDINES AND THEIR METHODS OF USE | |
| ITRE990019A0 (it) | Dispositivo per la registrazione temporanea e/o permanente di eventi i mprovvisi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |